title: Ulcerogenic and intestinal motility/transit stimulating actions of nevirapine in albino Wistar rats.
abstract: The antiretroviral is a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. This study was undertaken to investigate the effect of nevirapine (NVP) administration on gastric acid secretion, pepsin secretion, mucosal secretion, intestinal motility, and transit using apparently healthy albino Wistar rats. Eighty albino Wistar rats (50-125 g body weight) from the start of the experiment were used for the study. Rats in the control group were fed normal rodent chow, while the NVP group was fed by gavage NVP (0.4 mg/kg body weight) two times daily (07:00 and 18:00 hours) in addition to normal rodent chow for 12 weeks. All animals were allowed free access to clean drinking water. Mean basal gastric output and peak acid output following histamine administration in the NVP-treated group were significantly higher (p < 0.001, respectively) compared to the control. Following cimetidine administration, there was significant decrease (p < 0.001) in peak acid output in the NVP-treated group compared to the control. The concentration of gastric pepsin, adherent mucus secretion, and mean value for ulcer score were significantly higher (p < 0.001) compared to their control group, respectively. There were significant increases (p < 0.05, respectively) in intestinal motility and basal contraction (p < 0.05) and increase in intestinal transit of the ileum of NVP-treated rats compared to their control, respectively. Results of the study suggest that NVP administration might provoke gastric ulceration in rats which may be caused by high pepsin, high basal acid output, and increased intestinal motility and transit.
authors.affiliation: Department of Physiology, College of Medical Sciences, University of Calabar, Calabar, Nigeria. lizzyumoren@yahoo.com
authors.forename: Elizabeth Bassey
authors.initials: EB
authors.lastname: Umoren
authors.forename: Agona Odeh
authors.initials: AO
authors.lastname: Obembe
authors.forename: Eme Effiom
authors.initials: EE
authors.lastname: Osim
mesh_terms: D000284:Administration, Oral; D000818:Animals; D002927:Cimetidine / Q000494:pharmacology; D005744:Gastric Acid / Q000378:metabolism; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology; D019829:Nevirapine / Q000009:adverse effects*; D010434:Pepsin A / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D013270:Stomach / Q000187:drug effects* / Q000473:pathology; D013276:Stomach Ulcer / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology
chemical_list: D018894:Reverse Transcriptase Inhibitors; D002927:Cimetidine; D006632:Histamine; D019829:Nevirapine; D010434:Pepsin A
references.citation: Gut. 1986 Mar;27(3):243-8
references.pmid: 3084340
references.citation: J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):303-8
references.pmid: 12352517
references.citation: Hepatology. 2002 Feb;35(2):500-1
references.pmid: 11826431
references.citation: Physiol Rev. 2008 Oct;88(4):1547-65
references.pmid: 18923189
references.citation: West Afr J Med. 2003 Jan-Mar;22(1):1-4
references.pmid: 12769295
references.citation: AIDS. 2002 Jul 5;16(10):1419-20
references.pmid: 12131219
references.citation: J Gastroenterol. 2012 Feb;47(2):150-8
references.pmid: 22038552
references.citation: JAMA. 1998 Feb 11;279(6):450-4
references.pmid: 9466638
references.citation: Br J Clin Pharmacol. 2005 Sep;60(3):291-9
references.pmid: 16120068
references.citation: Gastroenterology. 1981 Apr;80(4):770-5
references.pmid: 6162705
references.citation: Gastroenterology. 1991 Nov;101(5):1149-58
references.pmid: 1936784
references.citation: Equine Vet J. 1997 Nov;29(6):430-3
references.pmid: 9413714
references.citation: Dig Dis Sci. 1986 Feb;31(2 Suppl):126S-129S
references.pmid: 3080283
references.citation: AIDS. 1998 Sep 10;12(13):1619-24
references.pmid: 9764780
references.citation: Am J Physiol. 1983 Sep;245(3):G388-93
references.pmid: 6614182
references.citation: JAMA. 2000 Jan 19;283(3):381-90
references.pmid: 10647802
references.citation: AIDS Res Hum Retroviruses. 2002 Jul 20;18(11):757-70
references.pmid: 12167267
references.citation: J Clin Gastroenterol. 1983;5 Suppl 1:81-90
references.pmid: 6317740